Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea.
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2014
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriasis; Sleep apnoea syndrome
- Focus Therapeutic Use
- 26 Jul 2012 Primary endpoint 'Apnea-hypopnea-index' has not been met.
- 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2011 Planned end date changed from 1 Dec 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History